CollPlant Biotechnologies Ltd. (CLGN) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CLGN Revenue Growth
Revenue Breakdown
CLGN's revenue distribution by segment and geography
By Geography
CLGN Revenue Analysis (2013–2024)
As of May 8, 2026, CollPlant Biotechnologies Ltd. (CLGN) generated trailing twelve-month (TTM) revenue of $2.5 million, reflecting explosive growth of +1825.0% year-over-year. The most recent quarter (Q3 2025) recorded $77,000 in revenue, down 57.0% sequentially.
Looking at the longer-term picture, CLGN's 5-year compound annual growth rate (CAGR) stands at -26.0%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $15.6 million in 2021.
When compared to Healthcare sector peers including RGEN (+17.4% YoY), HALO (+37.6% YoY), and AGIO (+78.3% YoY), CLGN has outperformed the peer group in terms of revenue growth. Compare CLGN vs RGEN →
CLGN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CLGNCurrent | $2M | +1825.0% | -26.0% | -3349.7% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 AGIO | $54M | +78.3% | - | -873.9% | |
 ITGR | $1.8B | +6.0% | +11.5% | 11.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
CLGN Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $515K | -95.3% | $-2,148,000 | -417.1% | $-17,251,000 | -3349.7% |
| 2023 | $11.0M | +3565.2% | $7.9M | 71.8% | $-7,512,000 | -68.5% |
| 2022 | $299K | -98.1% | $-1,177,000 | -393.6% | $-17,097,000 | -5718.1% |
| 2021 | $15.6M | +154.9% | $13.6M | 87.2% | $65K | 0.4% |
| 2020 | $6.1M | +164.8% | $2.7M | 43.7% | $-5,599,000 | -91.2% |
| 2019 | $2.3M | -51.6% | $52K | 2.2% | $-7,631,000 | -329.2% |
| 2018 | $4.8M | +897.8% | $3.1M | 65.0% | $-4,065,636 | -84.9% |
| 2017 | $480K | +532.2% | $158K | 32.8% | $-5,971,055 | -1244.2% |
| 2016 | $76K | - | $-149,006 | -196.3% | $-7,160,869 | -9433.2% |
| 2015 | $0 | - | $-202,819 | - | $-4,819,580 | - |
See CLGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CLGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCLGN — Frequently Asked Questions
Quick answers to the most common questions about buying CLGN stock.
Is CLGN's revenue growth accelerating or slowing?
CLGN revenue is accelerating at +1825.0% year-over-year, exceeding the 5-year CAGR of -26.0%. TTM revenue reached $2M. Growth momentum has increased versus prior periods.
What is CLGN's long-term revenue growth rate?
CollPlant Biotechnologies Ltd.'s 5-year revenue CAGR of -26.0% reflects the sustained expansion pattern. Current YoY growth of +1825.0% is above this long-term average.
How is CLGN's revenue distributed by segment?
CLGN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.